Veeva Systems downgraded by Goldman with a new price target
$VEEV
Computer Software: Prepackaged Software
Technology
Goldman downgraded Veeva Systems from Buy to Sell and set a new price target of $200.00 from $261.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/29/2025 | $270.00 → $300.00 | Buy | Needham |
| 1/23/2025 | $261.00 → $200.00 | Buy → Sell | Goldman |
| 12/20/2024 | $280.00 | Overweight | Stephens |
| 12/4/2024 | $275.00 | Outperform | Mizuho |
| 11/19/2024 | $235.00 | Sector Perform | Scotiabank |
| 10/8/2024 | $286.00 | Outperform | Exane BNP Paribas |
| 8/27/2024 | $256.00 → $273.00 | Buy | Citigroup |
| 7/9/2024 | $240.00 | Buy | BTIG Research |
More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speed PLEASANTON, Calif., June 11, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that more than 50 medtech companies, including 11 of the top 20 medtechs and seven of the top 10 medtech clinical research organizations (CROs), have selected Veeva Clinical Platform applications to simplify and streamline medical device and diagnostics studies. With increasing regulatory requirements and evolving markets, medtech companies are moving away from siloed legacy solutions to modern connected applications from Veeva MedTech.
Industry focused on automation, connectivity, and reporting for proactive quality management PLEASANTON, Calif., June 9, 2025 /PRNewswire/ -- The 2025 Veeva MedTech Postmarket Quality Benchmark Report reveals that 88% of the medtech companies surveyed are advancing postmarket quality management within the next three years to improve compliance and drive innovation. This signals a shift toward modernization to reduce risk and foster a stronger culture of quality across the product lifecycle. While the move to more scalable solutions is planned or underway for most, 68% of medte
Vault CRM will support Astellas' commercial agility and execution PLEASANTON, Calif., June 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced Astellas has chosen Veeva Vault CRM globally and Veeva China CRM for China. "At Astellas, we discover and deliver transformative therapies for patients around the world," said Nick Eshkenazi, chief digital and transformation officer at Astellas. "Having a foundation for commercial agility and execution is crucial. Our collaboration with Veeva will provide us with technology solutions and data to enhance our agility as a co
144 - VEEVA SYSTEMS INC (0001393052) (Subject)
DEFA14A - VEEVA SYSTEMS INC (0001393052) (Filer)
10-Q - VEEVA SYSTEMS INC (0001393052) (Filer)
Needham reiterated coverage of Veeva Systems with a rating of Buy and set a new price target of $300.00 from $270.00 previously
Goldman downgraded Veeva Systems from Buy to Sell and set a new price target of $200.00 from $261.00 previously
Stephens initiated coverage of Veeva Systems with a rating of Overweight and set a new price target of $280.00
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)